The second decade of anti-TNF-a therapy in clinical practice: new lessons and future directions in the COVID-19 era
PDF) Integrating imaging and biomarker assessment to better define psoriatic arthritis and predict response to biologic therapy
Frontiers Introducing Patterns of Variability for Overcoming Compensatory Adaptation of the Immune System to Immunomodulatory Agents: A Novel Method for Improving Clinical Response to Anti-TNF Therapies
Clinical guidelines for TNF inhibitor use [5]
Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019 - eClinicalMedicine
Frontiers Personalize, participate, predict, and prevent: 4Ps in inflammatory bowel disease
Effectiveness of Apremilast in Real Life in Patients with Psoriasis: A Longitudinal Study, HTML
PDF) Long-term persistence of TNF-inhibitor treatment in patients with psoriatic arthritis. Data from the British Society for Rheumatology Biologics Register
Gene polymorphisms that can predict response to anti-TNF therapy in patients with psoriasis and related autoimmune diseases
Journal of Psoriasis and Psoriatic Arthritis
Longterm Clinical Outcomes in 420 Patients with Psoriatic Arthritis Taking Anti-tumor Necrosis Factor Drugs in Real-world Settings
New insights into the pathogenesis and genetics of psoriatic arthritis